Recombinant Antibody Expression

Home » Product & Services » Antibody Service » Recombinant Antibody Expression
Overview
With the advancement of biotechnology, high-quality, highly specific antibodies have not only become effective tools for protein identification and localization but have also been directly employed in the diagnosis and treatment of diseases.

To address a wide range of needs and advance biotechnology, Tsingke introduces the Fast Recombinant Antibody Expression Service. Utilizing a high-throughput transient transfection antibody expression platform, we achieve rapid delivery of recombinant antibodies in as little as one week.
Advantages
Fast Turnaround
The comprehensive expression service platform connects design, synthesis, and purification processes
High Expression Yield
Selected high-expression strains and optimized vectors, coupled with a refined process system
High Throughput
Swiftly process up to 800 samples per run for efficient delivery

Service Details

Service Name

Expression system

Service Code

Volume

Turnaround time

Recombinant Antibody Expression Service
Anti-dsDNA antibodies,single chain antibody fragmen, VHH-His, VHH-FC, Fab, etc.

HEK293/CHO

Tsingke-006-3

10 mL

1~2 weeks

Tsingke-006-4

20 mL

Tsingke-006-5

30 mL

Tsingke-006-6

40 mL

Tsingke-006-7

50 mL

Tsingke-006-8

100 mL

Tsingke-006-9

200 mL

Tsingke-006-10

500 mL

Tsingke-006-11

1000 mL

Tsingke-006-12

>1 L


Deliverables

Delivery Standard

Purified antibodies;

COA Report(electronic);

Optional:Antibody gene in commercial vectors.

SDS-PAGE&SEC-HPLC >95%;

Endotoxin level <1 EU/mg.

Workflow
Workflow
Case
Figure 1. Anti-dsDNA Antibody Service Order
Figure 2. VHH-FC Antibody Service Order


Related Resource
**For Research Use Only. Not for use in diagnostic procedures.
Send Your Request
Want to learn more about these services? Speak to our experts and get a free quote.
Those with * are required
pop_close
pop_main
Subscribe to Our Newsletter
Stay updated with the latest industry news and expert insights. Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!